NCT03778593 2021-02-04
FOLFIRINOX for 2nd-line Treatment of BTC
Dong-A University Hospital
Phase 2 Completed
Clinical Trials
4 trialsNCT00948935 2020-03-11
Study of Gemcitabine, Irinotecan and Panitumumab in Patients With Advanced and Metastatic Biliary Tract Adenocarcinoma
Abramson Cancer Center at Penn Medicine
Phase 2 Completed
NCT02558959 2018-02-13
Second-line Irinotecan and Capecitabine Versus Irinotecan for Gemcitabine and Cisplatin Refractory Biliary Tract Cancer
Zhejiang University
Phase 2 Completed
NCT00832689 2011-03-28
Irinotecan, Gemcitabine, Chemotherapy for Biliary Tract Cancer
Yonsei University
Phase 2 Completed